Clinical Trial

CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-05-20
notable Primary completion pushed: 2027-07 -> 2028-05 2026-05-20
minor Completion pushed: 2027-11 -> 2028-05 2026-05-20
Trial Details
NCT Number NCT07276711
Lead Sponsor EmStop Inc
Collaborators: Bright Research Partners
Conditions Aortic Valve Stenosis, Aortic Stenosis, Aortic Valve Disease
Enrollment 663 participants
Start Date 2026-05-12
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-26